Case file · Mar 11, 2024
Rep. Lisa McClain bought $NVDA
What Happened Next
$NVDA vs the S&P 500 from the trade date. A buy has an edge when the stock beats the market.
$NVDA · 30 days
+1.5%
S&P 500, same days
+0.9% +0.6 pts edge
$NVDA · 90 days
+42.0%
S&P 500, same days
+5.1% +36.9 pts edge
$NVDA · 180 days
+24.1%
S&P 500, same days
+7.6% +16.6 pts edge
Return
0+20%+40%+60%+80%
The Paper Trail
- $NVDA moved +42.0% in the 90 days after the buy, vs +5.1% for the S&P 500 — a 36.9-point edge
- 9 days before: Khanna and Jackson chip-stock cluster trades around Intel CHIPS Act preliminary $8.5B memo source
- Disclosed 520 days after the buy — 475 days past the 45-day STOCK Act deadline
- Filed as a spouse's trade
- Trade date
- Mar 11, 2024
- Disclosed
- Aug 14, 2025 (520 days)
- Shuffle Score
- 22/100
- Filing
- Not linked
Lisa McClain's History in $NVDA
| Date | Type | Amount | Owner |
|---|---|---|---|
| Mar 11, 2024 | Buy | $15,001 - $50,000 | Spouse |
| Jun 6, 2024 | Buy | $50,001 - $100,000 | Spouse |
| Oct 23, 2024 | Sell | $100,001 - $250,000 | Spouse |
| Nov 7, 2024 | Buy | $100,001 - $250,000 | Spouse |
| Dec 11, 2024 | Buy | $1,001 - $15,000 | Spouse |
| Jun 9, 2025 | Buy | $1,001 - $15,000 | Spouse |
| Jun 10, 2025 | Sell | $1,001 - $15,000 | Spouse |
| Jun 11, 2025 | Buy | $1,001 - $15,000 | Spouse |
| Jun 17, 2025 | Buy | $1,001 - $15,000 | Spouse |
| Jun 26, 2025 | Sell | $50,001 - $100,000 | Spouse |
| Oct 30, 2025 | Sell | $15,001 - $50,000 | Spouse |
| Oct 30, 2025 | Buy | $15,001 - $50,000 | Spouse |
| Oct 31, 2025 | Sell | $15,001 - $50,000 | Spouse |
Who Else Traded $NVDA That Week
Other members of Congress with trades in the same stock within 7 days either side
| Politician | Date | Type | Amount |
|---|---|---|---|
| Tom Suozzi Dem | Mar 4, 2024 | Sell | $15,001 - $50,000 |
| Tom Carper Dem | Mar 7, 2024 | Buy | $1,001 - $15,000 |
| John James Rep | Mar 13, 2024 | Buy | $1,001 - $15,000 |
Returns use split- and dividend-adjusted closes. Disclosures report ranges, not exact amounts. A well-timed trade is not evidence of wrongdoing. Methodology · Disclaimer